8-K: 180 Life Sciences Secures $156M Debt for ETH Strategy

180 Life Sciences Corp. closed a $156.25 million senior secured convertible note offering to boost its Ethereum holdings and announced new strategic advisor warrants and executive stock options.

Summary

• Closed a private offering of $156.25 million in senior secured convertible notes, with a purchase price of 96.0% of the principal amount.
• The notes bear 0.00% interest for the first six months, then 4.00% per annum, increasing to 18.0% upon an event of default.
• The initial conversion price for the notes is $3.445 per share, subject to a one-time downward reset after nine months.
• The notes are secured by $44.5 million in Ether (ETH) and approximately $156.25 million in cash collateral.
• Granted additional strategic advisor warrants for 9,071,110 shares of common stock at an exercise price of $3.445 per share.
• Appointed McAndrew Rudisill as Executive Chairman, effective August 7, 2025, and formed an Investment Committee to oversee digital assets.
• Adopted the 2025 Second Supplemental Option Incentive Plan, reserving 1,814,221 shares for awards, subject to stockholder approval within 12 months.
• Granted stock options under the new plan to CEO Blair Jordan (771,044 shares), Lead Director Ryan Smith (771,044 shares), Independent Director Stephen Shoemaker (181,422 shares), and outside legal counsel (90,771 shares), all with an exercise price of $3.01 per share.
• Proceeds from the notes will primarily be used to acquire more ETH, acquire certain yield-bearing assets, continue iGaming operations, and monetize biotech intellectual property.
• Company plans to rebrand as ETHZilla Corporation, focusing on an ETH accumulation vehicle and a differentiated yield generation program.

Sentiment

Score: 4

Explanation: While the company secured significant financing and is pursuing an innovative digital asset strategy, the substantial potential for dilution, the high-risk nature of cryptocurrency investments, and the senior secured status of the debt (which prioritizes noteholders over other assets in default) present considerable downside risks for existing shareholders. The pivot into a highly volatile and uncertain market (crypto) from traditional biotech/iGaming adds a layer of speculative risk.

Positives

• Secured significant debt financing of $156.25 million, strengthening the balance sheet for its new digital asset strategy.
• The convertible notes feature a low initial interest rate of 0.00% for the first six months, transitioning to 4.00% per annum thereafter.
• Strategic focus on increasing Ethereum (ETH) holdings and developing a yield generation program, aligning with evolving digital asset market trends.
• Appointment of McAndrew Rudisill as Executive Chairman and the formation of a dedicated Investment Committee to oversee digital assets, enhancing governance in this new area.
• Successfully completed a prior $350 million equity PIPE offering, indicating investor confidence in the company's strategic direction.

Negatives

• Significant potential for dilution from the convertible notes (up to 45,355,588 shares) and strategic advisor warrants (9,071,110 shares).
• The convertible notes carry a high default interest rate of 18.0% per annum, indicating elevated risk if financial covenants are breached.
• The notes are senior secured by $44.5 million in ETH and $156.25 million in cash, meaning these assets are prioritized for noteholders in a default scenario, potentially limiting recovery for other creditors or shareholders.
• Company must maintain specific financial covenants, including a minimum of $5 million in available cash (outside blocked accounts) and a loan-to-value ratio of no more than 100%, with failure triggering an Event of Default.
• Stock options granted to management and directors have an exercise price ($3.01) that is only slightly above the closing sale price on the grant date, potentially limiting immediate upside for option holders if the stock price does not significantly increase.
• Stockholder approval is required for the full conversion of notes beyond a 19.99% exchange cap and for the new option plan, introducing uncertainty and potential delays.

Risks

• Stockholders may experience significant dilution as a result of the conversion of the convertible notes and exercise of warrants.
• The convertible notes contain covenants that limit the company's flexibility, potentially restricting its ability to raise additional capital or pursue strategic opportunities.
• The notes are secured by a significant portion of the company's assets, including $44.5 million of Ether and $156.25 million in cash, which could be seized by noteholders in the event of a default, leading to a loss of value for other investments.
• The company's stock price may be highly correlated to the volatile price of Ether and other cryptocurrencies, introducing substantial market risk.
• There is significant legal, commercial, regulatory, and technical uncertainty regarding digital assets generally, which could adversely impact the company's new treasury strategy.
• Risks exist relating to the treatment of crypto assets for U.S. and foreign tax purposes, which could affect the company's financial performance.
• Failure to realize the anticipated benefits of the debt financing and the proposed digital asset treasury strategy could negatively impact the company's prospects.
• Increased competition in the industries in which the company operates (iGaming, biotech, and digital assets) poses a challenge.
• Failure to obtain required stockholder approval for the issuance of shares upon conversion of notes (beyond the 19.99% cap) or for the 2025 Option Incentive Plan could hinder strategic plans.
• The company faces the risk of not satisfying Rule 144(c)(1) requirements for current public information, which could impede the resale of Registrable Securities by investors.
• There is a risk of actions designed to cause or result in the stabilization or manipulation of the price of any company security.

Future Outlook

The company intends to use the net proceeds from the convertible note offering primarily to rapidly increase its ETH holdings, further expanding its digital asset treasury strategy. It plans to rebrand as ETHZilla Corporation and focus a significant portion of its non-legacy operations on becoming an ETH accumulation vehicle built for the community. The company aims to pursue a differentiated yield generation program meant to outperform traditional ETH staking through its partnership with Electric Capital. Regular updates on Ethereum holdings will be provided for transparency.

Management Comments

• "The Convertible Note offering further strengthens our balance sheet and will be used to increase our ETH holdings."

Industry Context

This filing highlights 180 Life Sciences' aggressive pivot towards a digital asset treasury strategy, specifically focusing on Ethereum (ETH), and its planned rebranding to ETHZilla Corporation. This move positions the company as an early adopter among publicly traded entities seeking direct exposure to and yield generation from cryptocurrency, differentiating it from traditional biotech or iGaming companies. The strategy aims to attract investors seeking exposure to the Ethereum network, potentially setting a benchmark for on-chain treasury management in the public market.

Comparison to Industry Standards

• The company's strategy to hold significant digital assets like ETH as a treasury strategy is highly unconventional for a publicly traded company, especially one previously focused on biotechnology and iGaming. Most public companies maintain treasuries in traditional fiat currencies and low-risk financial instruments.
• The interest rates on the convertible notes (0% for 6 months, then 4%) are competitive for secured debt, but the 18% default rate is high, reflecting the perceived risk of the underlying collateral (ETH volatility) and the company's new, unproven treasury strategy.
• The substantial dilution potential from the convertible notes and warrants is significant compared to typical equity raises for established companies, but may be considered standard for high-growth or speculative ventures entering new, volatile markets.
• The formation of a dedicated Investment Committee for digital assets is a necessary governance step for a company adopting such a treasury strategy, aligning with best practices for managing novel asset classes.

Management Changes

Corporate Governance

Related Party Transactions

• Subsequent Strategic Advisor Warrants to purchase 957,002 shares of Common Stock were granted to PCAO, an entity of which Mr. McAndrew Rudisill, the Chairman of the Company, is the founder and managing partner.
• Stock options were granted to Blair Jordan (Chief Executive Officer), Ryan Smith (Lead Director), and Stephen Shoemaker (independent member of the Board of Directors).

Stakeholder Impact

• Shareholders face significant potential for dilution from the convertible notes and warrants. The company's pivot to a digital asset treasury strategy introduces high volatility and speculative risk, potentially impacting share price. Existing shareholders' equity may be subordinated to the secured debt in a default scenario.
• Employees and management benefit from the new stock option plan and grants, providing incentives, though exercise is contingent on stockholder approval.
• Creditors (other than noteholders) may face limited recovery in case of default, as $44.5 million in ETH and $156.25 million in cash are pledged as collateral to the senior secured convertible noteholders.
• Strategic Advisors received additional warrants, aligning their interests with the company's new digital asset strategy.

Next Steps

• Company to file a resale registration statement for shares underlying the Convertible Notes within 15 calendar days of the Effective Date.
• Company to seek stockholder approval for the issuance of shares upon conversion of the Convertible Notes (beyond 19.99% cap) within 90 calendar days of the Closing Date, with subsequent meetings semi-annually if not obtained.
• Company to seek stockholder approval for the 2025 Second Supplemental Option Incentive Plan within 12 months of its adoption.
• Company plans to rebrand as ETHZilla Corporation.
• Company plans to provide regular updates on its Ethereum holdings.
• Company plans to pursue a differentiated yield generation program for ETH through a partnership with Electric Capital.

Key Dates

Recommendation

The company has secured substantial financing and is making a bold strategic pivot into the digital asset space, which could offer significant upside if successful. However, this move introduces high volatility and regulatory risks associated with cryptocurrencies. The potential for substantial shareholder dilution from the convertible notes and warrants, coupled with the senior secured nature of the debt, creates considerable downside risk. Investors should hold to observe the execution of the new treasury strategy and its impact on financial performance and risk profile, while closely monitoring ETH price movements and regulatory developments.

Keywords

Convertible Notes, Ethereum, Digital Assets, Cryptocurrency, Debt Financing, Strategic Advisor Warrants, Stock Options, Dilution, Corporate Governance, Risk Management, SEC Filings, Capital Raise, Nasdaq, Biotechnology, iGaming, Treasury Strategy